- Jun 18, 2013 Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue
- May 20, 2013 Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue
- May 20, 2013 Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company
- May 13, 2013 Announcement Under Irish Takeover Rules Relevant Securities in Issue
- May 10, 2013 Warner Chilcott Statement Regarding Market Speculation
- May 10, 2013 Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013
- May 9, 2013 Warner Chilcott Announces FDA Approval of New Oral Contraceptive
- May 7, 2013 Warner Chilcott Declares Semi-Annual Cash Dividend of $0.25 Per Share
- May 2, 2013 Warner Chilcott Announces Changes to Board of Directors
- May 1, 2013 Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2013 Financial Results
- Apr 22, 2013 Warner Chilcott Announces FDA Approval of New Oral Contraceptive
- Apr 12, 2013 Warner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg Tablets
- Mar 4, 2013 Warner Chilcott to Present at the 2013 Goldman Sachs Leveraged Finance Healthcare Conference
- Feb 22, 2013 Warner Chilcott to Present at the 2013 RBC Capital Markets Healthcare Conference
- Feb 22, 2013 Warner Chilcott to Present at the 2013 Citi Global Healthcare Conference
- Feb 22, 2013 Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2012
- Feb 18, 2013 Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2012 Financial Results
- Feb 8, 2013 Warner Chilcott Announces 2013 Financial Guidance
- Feb 5, 2013 Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
- Feb 4, 2013 Warner Chilcott Announces 2013 Financial Guidance Conference Call
WCRX - NASDAQ